Autolus Therapeutics Company
Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Technology:
CAR-T therapy
Industry:
Public
Headquarters:
London, England, United Kingdom
Founded Date:
2014-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
10
Total Funding:
781600000
Estimated Revenue:
$50M to $100M
Last Funding Date:
2022-12-08
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership